近日，AI蛋白质设计平台「百奥几何」顺利完成Pre-A轮融资，标志着该公司的发展迈入新的阶段。本轮融资由将门创投领投，智谱AI、盛景嘉成跟投，老股东高榕创投也持续追加投资。
「百奥几何」是一家成立于2021年的高科技企业，专注于开发生成式AI蛋白质设计平台，赋能生物制造领域。此次融资所得资金将主要用于加速生成式AI大模型在生物制造领域的落地应用，以及推进自有产品的开发。
随着科技的不断进步，AI在生物制造领域的应用越来越广泛。而「百奥几何」的生成式AI蛋白质设计平台，能够利用人工智能技术优化蛋白质设计，从而提高生物制造的效率和质量。
公司创始人表示，这次融资将为「百奥几何」的发展注入新的动力，推动公司在生物制造领域取得更大的突破。未来，「百奥几何」将继续致力于研发更多创新技术，为生物制造领域的发展做出更大的贡献。
老股东高榕创投对「百奥几何」的投资信心坚定，认为该公司具备强大的技术实力和广阔的市场前景。此次融资的成功，无疑将为「百奥几何」的发展开启新的篇章。
英语如下：
News Title: “Biotech Geometry” Successfully Raises Funds to Accelerate the Application of Generative AI in Biomanufacturing
Keywords: Biotech Geometry funding, Capital Utilization, Biomanufacturing Enablement
News Content:
“Biotech Geometry” Completes Pre-A Round of Funding to Accelerate the Application of Generative AI in Biomanufacturing
Recently, the AI protein design platform “Biotech Geometry” successfully completed its Pre-A round of funding, marking a new stage in the company’s development. This round of funding was led by Jiangmen Ventures, followed by Zhipu AI and Shengjing Jiacheng, with continuous additional investment from existing shareholder Gaorong Ventures.
“Biotech Geometry” is a high-tech enterprise established in 2021, specializing in the development of generative AI protein design platforms to enable the biomanufacturing industry. The funds raised from this financing will be used to accelerate the application of generative AI large models in the field of biomanufacturing and promote the development of its own products.
With the continuous advancement of technology, AI is increasingly being applied in the biomanufacturing industry. “Biotech Geometry’s” generative AI protein design platform can optimize protein design using AI technology, thereby improving the efficiency and quality of biomanufacturing.
The company’s founder stated that this financing will inject new momentum into the development of “Biotech Geometry” and push the company to make greater breakthroughs in the biomanufacturing field. In the future, “Biotech Geometry” will continue to develop more innovative technologies and make greater contributions to the development of the biomanufacturing industry.
Existing shareholder Gaorong Ventures has strong confidence in “Biotech Geometry”, believing in the company’s strong technological capabilities and broad market prospects. The success of this financing will undoubtedly open a new chapter for “Biotech Geometry” ‘s development.
【来源】https://ai-bot.cn/go/?url=aHR0cHM6Ly93d3cuMzZrci5jb20vcC8yODI1NTI3MjIxMjc0ODg0
Views: 1